Prospective observational study for perioperative volume replacement with 6% HES 130/0,42, 4% gelatin and 6% HES 200/0,5 in cardiac surgery

European Journal of Medical Research

Volumn 15, Issue 9, 2010, Pages 383-389

  Winterhalter, Michael ^a   Malinski, P ^b   Danzeisen, O ^a   Sixt, S ^a   Monaca, E ^a   Juttner T ^a   Peiper, M ^a   Kienbaum, R ^a   Koester, A ^a   Rahe Meyer, N ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; APROTININ; BICARBONATE; COLLAGEN; DOBUTAMINE; FRESH FROZEN PLASMA; GELAFUNDIN; GELATIN; HEMOHES; HEPARIN; HETASTARCH; NORADRENALIN; PLASMA SUBSTITUTE; PROTAMINE; SODIUM CHLORIDE; THROMBOCYTE CONCENTRATE; UNCLASSIFIED DRUG; VENOFUNDIN; BLOOD CLOTTING FACTOR; CATECHOLAMINE;

ADULT; AGED; ANALYZER; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BLOOD GAS; CIRCULATION; CLINICAL TRIAL; COLLOID; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTIVE SURGERY; ERYTHROCYTE CONCENTRATE; FEMALE; FLUID RESUSCITATION; HEART LUNG MACHINE; HEART SURGERY; HEMODYNAMICS; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OPEN HEART SURGERY; PERIOPERATIVE PERIOD; PROSPECTIVE STUDY; SURGICAL PATIENT; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; URINARY EXCRETION; AORTA VALVE REPLACEMENT; AORTIC VALVE REPAIR; ARTERY GRAFT; BLEEDING; CORONARY ARTERY BYPASS GRAFT; ELECTRODE; MITRAL VALVE REPAIR; MITRAL VALVE REPLACEMENT; VEIN GRAFT;

EID: 77957898544     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: 10.1186/2047-783x-15-9-383     Document Type: Article

References (26)

1. Knotzer H, Maier S, Dünser MW, Ulmer H, Schwarz B, et al. Comparison of lactated Ringer's, gelatine and blood resuscitation on intestinal oxygen supply and mucosal oxygen tension in haemorrhagic shock. Br J AnaesthBr J Anaesth. 2006;97:509-516.
2. Hillman K, Bristow P. The crystalloid versus colloid controvery: present status. Balliere's Clin Anaesth. 1997; 11:1-13.
3. Otsuki DA, Margarido CB, Marumo CK, Intelizano T, Pasqualucci CA, et al. Hydroxyethyl starch is superior to Ringer as a replacement fluid in a pig model of acute normovolaemic haemodilution. Br J Anasth. 2007; 98: 29-37.
4. Boldt J, Andinet A. New Plasma-Adapted Hydroxyethyl-starch Preparation: In vitro Coagulation Studies Using Thrombelastography and Whole Blood Aggregometry. Anesth Analg. 2007; 104: 425-430.
5. Langeron O, Ang E-T, Bonnet F, Capdevila X, Coriat P. Voluven®, a Lower Substituted Novel Hydroxyethyl Starch (HES 130/0.4), Causes Fewer Effects on Coagulation in Major Orthopedic Surgery than HES 200/0.5. Anesth Analg. 2001; 92: 855-862.
6. Treib J, Grauer MT, Strauss RG. An international view of hydroxyethyl starches. Intensive Care Med. 1999; 25: 258-268.
7. Laxenaire MC, Feldman L. Reactions anaphylactoides aux substituts colloideaux du plasma: incidence, facteurs de risque, mécanismes. Ann Fr Anesth Réanim. 1994; 13: 301-310.
8. Boldt J. Modern Rapidly Degradable Hydroxyethyl Starches:Current Concepts. Anesth Analg, 2009; 108: 1574-1582.
9. Gallandat H, Baus D et al. A novel hydroxyethyl starch (Voluven®) for effective perioperative plasma volume substitution in cardiac surgery. Can J Anesth. 2000; 47: 1207-1215.
10. Günther Haisch JB, Krebs C, Suttner S. Influence of a New Hydroxyethylstarch Preparation (HES 130/0.4) on Coagulation in Cardiac Surgical Patients. J Cardiothor Vasc Anesthesia. 2001; 15: 316-321.
11. Kasper SM, Kampe S, Görg C, Geisen C, Mehlhorn U, Diefenbach C. Large-dose hydroxyethyl starch 130/0.4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200/0.5 at recommended doses. Anesthesiology. 2003; 99: 42-7.
12. Scharbert G, Marschalek C, Kozek-Langenecker SA. The Effects of Test Temperature and Storage Temperature on Platelet Aggregation: A Whole Blood In vitro Study. Anesth Analg. 2006; 102: 1280-4.
13. Bruckenberger E. Herzbericht 2007. 2007 [cited 02.08. 2009]; Available from: http://www.bruckenberger.de.
14. Friedrich I, Kötting J, Thölen F, Fischer B Silber R-E. Cardiac Surgery in the Elderly Patient. Dtsch Arztebl Int. 2009; 106: 412-422.
15. Schiffl H. Renal recovery after severe acute renal injury. Eur J Med Res. 2008; 13: 552-556.
16. Wiebe K, Wahlers T, Zenker D, Schulze F, Michels P, Dalichau H, Mohr FW, Borst H, Forssmann WG. Acute renal failure following cardiac surgery is reverted by administration of Urodilatin (INN: Ularitide). Eur J Med Res. 1996; 1: 259-265.
17. Neff TA, Jungheinrich C, Saucrland A, Spahn DR, Stocker R. Repetitive large-dose infusion of the novel hydroxyethyl starch 130/0.4 in patients with severe head injury. Anesth Analg. 2003; 96: 1453-1459.
18. Boldt J, Röhm K, Papsdorf M, Mengistu A. Comparison of the effects of gelatin and a modern hydroxyethyl starch solution on renal function and inflammatory response in elderly cardiac surgery patients. Brit J Anaesthesia. 2008; 100: 457-464.
19. Innerhofer P, Margreiter J, Klingler A, Kühbacher G, Wachter B, et al. The effects of perioperatively administered colloids and crystalloids on primary platelet-mediated hemostasis and clot formation. Anesth Analg. 2002; 95: 858-865.
20. Van der Linden PJ, Daper A, Trenchant A, Schmartz D, Defrance P, et al. 3,5% urea-linked gelatine is as effective as 6% HES 200/0.5 for volume management in cardiac surgery patients. Can J Anesth. 2004; 51: 236-241.
21. Van der Linden PJ, Deraedt D, Cromheecke S, De Decker K, De Paep R, et al. Hydroxyethyl starch 130/0.4 versus modified fluid gelatine for volume expansion in cardiac surgery patients: The effects on perioperative bleeding and transfusion needs. Anesth Analg. 2005; 101: 629-634.
22. Haisch G, Krebs C, Kumle B, Suttner S, Schulz A. The influence of intravascular volume therapy with a new hydroxyethyl starch preparation (6 % HES 130/0,4) on coagulation in patients undergoing major abdominal surgery. Anesth Analg. 2001; 92: 565-570.
23. Khalil PN, Ismail M, Khalil MN, von Knobelsdorff G, Marx G, Kalmar P. The critical role of aprotinin in controlling haemostasis in conjunction with non-pharmacological blood-saving strategies during routine coronary artery bypass surgery. Eur J Med Res. 2006; 11: 386-393.
24. Franz A, Gamsjäger T, Felfernig M, Gustorff B, Kozek-Langenecker SA., The effects of hydroxyethyl starches of varying molecular weights on platelet function. Anesth Analg, 2001. 92: 1402-1407.
25. Konrad CJ, Markl TJ, Schuepfer GK, Schmeck J, Gerber HR. In-Vitro effects of different medium molecular hydroxyethyl starch solutions and lactated Ringer's solution on coagulation using Sonoclot. Anesth Analg. 2000; 90: 274-9.
26. Felfernig M, Bräunlich P, Fohringer C, Kozek-Langenecker SA. The effects of hydroxyethyl starch solutions on thromboelastography in preoperative male patients. Acta Anaesthesiol Scand. 2003; 47: 70-73.